
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Graminex G63 Flower Pollen Extract,Norwegian Beta 1,3/1,6 Glucan
Therapeutic Area : Urology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Preliminary analysis indicated significant improvements were found in the Graminex® Flower Pollen Extract study group for multiple urinary incontinence quality of life indicators.
Product Name : Pollimmune
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 01, 2022
Lead Product(s) : Graminex G63 Flower Pollen Extract,Norwegian Beta 1,3/1,6 Glucan
Therapeutic Area : Urology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
